Cargando…
S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428452/ http://dx.doi.org/10.1097/01.HS9.0000968016.33010.55 |
| _version_ | 1785090472748777472 |
|---|---|
| author | Dillon, Stacey Davies, Rupert Lickliter, Jason Mclendon, Kristi Kristi L. Manjarrez, Kristi Smith, Alina Hudson, Krystalyn Blanchfield, Lori Sanderson, Russel Chunyk, Allison Blair, Tiffany Enstrom, Amanda Zayed, Hany Peng, Stanford |
| author_facet | Dillon, Stacey Davies, Rupert Lickliter, Jason Mclendon, Kristi Kristi L. Manjarrez, Kristi Smith, Alina Hudson, Krystalyn Blanchfield, Lori Sanderson, Russel Chunyk, Allison Blair, Tiffany Enstrom, Amanda Zayed, Hany Peng, Stanford |
| author_sort | Dillon, Stacey |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428452 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284522023-08-17 S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES Dillon, Stacey Davies, Rupert Lickliter, Jason Mclendon, Kristi Kristi L. Manjarrez, Kristi Smith, Alina Hudson, Krystalyn Blanchfield, Lori Sanderson, Russel Chunyk, Allison Blair, Tiffany Enstrom, Amanda Zayed, Hany Peng, Stanford Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428452/ http://dx.doi.org/10.1097/01.HS9.0000968016.33010.55 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Dillon, Stacey Davies, Rupert Lickliter, Jason Mclendon, Kristi Kristi L. Manjarrez, Kristi Smith, Alina Hudson, Krystalyn Blanchfield, Lori Sanderson, Russel Chunyk, Allison Blair, Tiffany Enstrom, Amanda Zayed, Hany Peng, Stanford S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES |
| title | S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES |
| title_full | S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES |
| title_fullStr | S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES |
| title_full_unstemmed | S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES |
| title_short | S276: POVETACICEPT (ALPN-303), A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF AUTOIMMUNE CYTOPENIAS AND OTHER ANTIBODY-RELATED DISEASES |
| title_sort | s276: povetacicept (alpn-303), a potent dual baff/april antagonist, for the treatment of autoimmune cytopenias and other antibody-related diseases |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428452/ http://dx.doi.org/10.1097/01.HS9.0000968016.33010.55 |
| work_keys_str_mv | AT dillonstacey s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT daviesrupert s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT lickliterjason s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT mclendonkristi s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT kristilmanjarrezkristi s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT smithalina s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT hudsonkrystalyn s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT blanchfieldlori s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT sandersonrussel s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT chunykallison s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT blairtiffany s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT enstromamanda s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT zayedhany s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases AT pengstanford s276povetaciceptalpn303apotentdualbaffaprilantagonistforthetreatmentofautoimmunecytopeniasandotherantibodyrelateddiseases |